Objectives. Clinical practice guidelines recommend standardized diagnostic microbiological testing for community-acquired pneumonia on hospital admission, although evidence of its impact on quality is limited. This study evaluated the relationship between guideline-concordant microbiological testing (GCMT) and both in-hospital mortality and length of stay.
Introduction
Community-acquired pneumonia is one of the most common infection-related conditions in developed countries and is a major cause of hospitalization and death, especially among older persons [1] . Thus, an improvement in the quality and outcome of community-acquired pneumonia treatment should result in enhanced independence and quality of life among older persons, as well as control of the increase in medical expenditure resulting from ageing of the population [2] . Several studies have shown that standardized care using clinical practice guidelines for community-acquired pneumonia treatment was independently associated with reduced mortality and length of stay [2] [3] [4] [5] .
The consensus guidelines published by the American Thoracic Society and the Infectious Diseases Society of America (ATS/ IDSA) in 2007, as well as other community-acquired pneumonia guidelines, recommend that hospitalized patients with pneumonia undergo diagnostic testing to identify the etiology of the community-acquired pneumonia. This is a moderate recommenblood cultures and urine antigen tests [6] . Theoretically, using a combination of microbiological tests rather than a single test could improve the accuracy of the etiological diagnoses and allow medical doctors to choose the most effective antibiotics [5, 6, 8] .
Nevertheless, routine practice of GCMT for patients with community-acquired pneumonia has been controversial [6] because its benefits remain unclear [5, [9] [10] [11] . Some studies reported that GCMT exhibited no significant effect on mortality or length of hospital stay [8] [9] [10] [11] . However, these studies tested the effectiveness of each GCMT component, rather than the set of three tests, and had relatively small sample sizes. Furthermore, prior studies may have been affected by several confounding issues including structural characteristics of the institutions, such as hospital size and case volume, protocol differences and other contextual differences, which may have led to null results.
We aimed to explore the association between use of a set of three GCMT components and clinical outcomes of patients with community-acquired pneumonia using a large sample derived from a multicenter administrative claims database in Japan.
Methods

Data source
We used the Japanese diagnosis procedure combination (DPC) inpatient database to obtain patient-level data. Details of the DPC database are described elsewhere [12] . Briefly, the DPC is a Japanese case-mix classification system for reimbursement by the public medical insurance scheme. All 82 university-affiliated main hospitals in Japan are required to adopt the system, whereas participation by other hospitals is voluntary. Participating hospitals are asked to submit electronic data on all discharges to the DPC Research Group, funded by the Ministry of Health, Labour and Welfare, Japan. In 2010, there were 3.19 million inpatients from 952 institutions in the database, representing ∼45% of all inpatient admissions to acute care hospitals in Japan.
The DPC database comprises discharge clinical summary and administrative claims information. Clinical summary data include hospital identifiers, patient demographics, discharge status, length of stay, major diagnosis, comorbidities and complications, as coded with the International Classification of Diseases, 10th Revision (ICD-10). The summary also includes adequate clinical information to determine the pneumonia severity index as described later. The administrative information includes the type, number and date of clinical procedures, such as operations, drug therapy, image diagnoses and laboratory examinations, coded in standardized claim codes.
To obtain hospital-specific structural characteristics about the number of beds, physicians, nurses and specialized services, such as intensive care units, we referred to the Survey of Medical Care Institutions and Hospital Report (the hospital census conducted by the Ministry of Health, Labour and Welfare) [13] . We linked the data from the two sources using unique hospital identifiers.
The collection and use of DPC data were approved by the Institutional Review Board of the university where the authors are affiliated with. The use of the Survey of Medical Care Institutions and Hospital Report data was approved by the Ministry of Health, Labour and Welfare for scientific purposes.
Study inclusion and exclusion criteria
Among those discharged between 1 July 2010 and 31 September 2011, we selected adult inpatients (aged 18 years or older) whose major diagnosis was pneumonia (ICD-10 J10-J18) (Fig. 1) . To exclude possible hospital-acquired pneumonia and healthcare-associated pneumonia, we excluded patients referred from non-pulmonary treatment units within the same institution or from other healthcare institutions and nursing homes. Patients were also excluded if they received dialysis, had a prior hospitalization in the last 90 days, had an immunecompromised status (including human immunodeficiency virus infection), or were transferred to other institutions for more specialized intensive treatment.
Clinical practice guidelines and recommendations
By referring to the 2007 ATS/IDSA guidelines and the 2009 update of the British Thoracic Society (BTS) guidelines for adult community-acquired pneumonia management, we selected sputum stains and cultures (sputum tests), blood cultures and urine antigen tests for Legionella or Pneumococcus as GCMTs for community-acquired pneumonia [7] . The sputum tests included expectorate sampling or respiratory tract sampling, although the type of sampling was not clearly categorized in the dataset. The guidelines recommend that sputum tests and blood cultures should be performed as soon Figure 1 Patient selection from the DPC database.
as possible after admission and before the initiation of any clinical treatment. We defined the performance of these tests within the first day of hospitalization as concordant with the guidelines, as we could not specify the exact time of treatment initiation because of limited information. Test performance dates were identified from administrative records. Patients were categorized by the number of GCMT components they underwent.
Endpoints
Our primary endpoint was 30-day in-hospital mortality. Our secondary endpoint was length of stay.
Covariates related to patient clinical conditions and hospital characteristics
We controlled for the potentially confounding effects of patient age, sex and comorbidities in the analyses. Pneumonia severity was evaluated using the A-DROP scoring system proposed by the Japanese Respiratory Society, which is a modified version of the BTS CURB-65 [14] , an easy-to-use system consistent with the ATS/IDSA Pneumonia Severity Index. A-DROP consists of scores for age (men ≥70 years; women ≥75 years), dehydration (blood urea nitrogen ≥7.5 mmol/l), respiratory failure ( pulse oximetry saturation; SpO 2 < 90%), orientation disturbance and low blood pressure (systolic blood pressure <90 mmHg). We divided the patients into four severity classes (mild, 0; moderate, 1 or 2; severe, 3 and very severe 4 or 5) according to the A-DROP algorithm. Emergency admission via ambulance and the use of intensive care units were also determined. We further investigated the type of unit in which the patients were treated (pulmonary unit or others). Previous studies identified several structural characteristics related to clinical outcomes, e.g., teaching status, hospital case volume, hospital size and staffing, represented as doctor-to-bed and nurse-to-bed ratios [15] . These structural characteristics were included in our analyses as potential confounders.
Statistical methods
Baseline characteristics of the patients and their admitting hospitals were compared across the number of GCMT components performed using one-way analysis of variance or χ 2 -tests as appropriate. The independent association between the number of GCMT components performed and in-hospital 30-day mortality was estimated using a multivariable logistic regression model adjusted for age, sex, orientation disturbance, respiratory failure, low blood pressure, dehydration, comorbidities, emergency admission via ambulance, use of intensive care units, university-affiliated major hospital status, treatment in a pulmonary unit, hospital volume, hospital size and doctor-to-bed and nurse-to-bed ratios. We further analyzed performance of the three GCMTs and their interaction terms in the regression model to identify any synergistic/antagonistic effects.
For length of stay, we used a Cox proportional hazards model to estimate hazard ratios (HRs) for hospital discharge. For this analysis, we excluded cases who died before discharge.
The reason was that inappropriate treatment of patients who died might bias length of stay towards a shorter range. For a robustness check of the analysis above, we performed propensity-adjusted analysis to control for selection bias due to selective use of GCMT [16] . Finally, we conducted the same analysis after stratifying by pneumonia severity to test whether the impact of GCMT varied across severity scores, because several studies indicated that the benefit of microbiological testing could differ by severity level [17, 18] . All statistical analyses were performed with STATA 12 SE (STATA Corp, College Station, TX, USA).
Results
Patient and hospital characteristics
We identified 65 145 patients with community-acquired pneumonia who were eligible for this study. Table 1 presents patient and hospital characteristics. The mean patient age was 74.3 years, and 37 787 (58%) were male. SpO 2 < 90% was observed among 33.0% of the patients. Approximately one-third of the patients experienced emergency admission via ambulance. Overall, the mean 30-day in-hospital mortality was 6.6%, and the mean length of stay was 18.8 days (median length of stay was 12 days).
Associations between microbiological testing and outcomes
The left column of Table 2 shows the adjusted odds ratios (ORs) for 30-day mortality for each GCMT component and their cumulative number. Each GCMT component and the cumulative number of GCMT components performed were significantly associated with decreased ORs for mortality, except for the sputum test. The cumulative number of GCMT components performed showed a dose-response relationship with decreasing in-hospital mortality. When three GCMTs and their two-way interaction terms were simultaneously tested in the model, the effect of blood culture and urine antigen tests remained independently significant (both P < 0.01), while the sputum test and its interaction terms did not reach statistical significance (not shown in the table).
The right column of Table 2 presents the results of a Cox proportional hazards analysis of length of stay, adjusting for the covariates used in the logistic regression for 30-day mortality. Performance of urine antigen tests was statistically associated with an increased HR for discharge (HR: 1.07; 95% confidence interval (CI), 1.05-1.10), while sputum tests and blood cultures were not significantly associated with length of stay. The cumulative number of GCMT components performed was significantly associated with higher HRs for discharge, although a dose-response relationship was not observed.
The results of the propensity-adjusted analysis were almost the same as those for the original multivariable-adjusted analyses (data not shown). However, the prediction power of the propensity models was low. The C-index reached only 0.58 in sputum tests, 0.68 in blood cultures and 0.64 in urine antigen tests. Excluding patients who died in hospital. OR, odds ratio; HR, hazard ratio for discharge; CI, confidence interval. Adjusted for age, sex, orientation disturbance, respiratory failure, low blood pressure, dehydration, comorbidities, emergency admission via ambulance, admission to intensive care units, university-affiliated main hospital, treatment in pulmonary unit, hospital volume, hospital size and doctor-to-bed and nurse-to-bed ratios.
Analysis stratified by disease severity
According to the A-DROP scores, 7935 pneumonia cases were categorized as very severe, 8224 as severe, 36 186 as moderate and 12 213 as mild. The 30-day mortality was 26.1% in very severe, 11.9% in severe, 3.4% in moderate and 0.3% in mild cases. Table 3 presents the multivariable logistic regression results for GCMT and 30-day mortality, stratified by severity. The observed reductions in the ORs of mortality were greater among the very severe and severe cases, compared with the mild and moderate cases. Table 4 presents the Cox proportional hazards regression results for GCMT and length of stay, stratified by severity class. The cumulative number of GCMT components was significantly associated with higher HRs for discharge in very severe and severe cases.
Discussion
Patients who underwent multiple GCMT for communityacquired pneumonia exhibited significantly lower odds of in-hospital mortality. The individual GCMT components, blood cultures and urinary antigen tests, but not the sputum tests, were associated with decreased ORs for mortality. Previous studies reported mixed results regarding the effectiveness of blood culture. Lee et al. [19] reported a null result, although their sample size was relatively small and the overall mortality was low, which may have influenced their null findings. In contrast, Meehan et al. [5] found a significant survival benefit attributed to collecting blood cultures within 24 h from admission in a large sample of patients aged 65 or older. The observed lack of association between sputum testing and decreased community-acquired pneumonia mortality is in accordance with the observations of previous studies [9, 10] . The diagnostic sensitivity of sputum tests is rather limited [20] , possibly because of inappropriately prepared sputum samples [10, 21] . However, Anevlavis et al. [22] reported that sputum tests were still of value in diagnostic testing when valid sputum samples were examined, and that the current practice of sputum testing may require improvements in the collection of good-quality sputum samples. Their argument may be concordant with our findings, because although there was no independent impact of the sputum test, there was a strong negative correlation between performance of all three GCMTs and in-hospital mortality. These findings suggest that combined use of different GCMTs may aid proper interpretation of sputum tests, though the interaction between sputum and other tests was not significant.
The analysis stratified by disease severity indicated that the magnitude of the association between GCMT and lower mortality was greater in more severe cases. Two previous studies also reported that intensive microbiological testing was more useful for etiological diagnosis of community-acquired pneumonia as its severity increased [17, 18] . These findings imply that compliance with the GCMT protocol could lead to improved outcomes, especially among cases with severe community-acquired pneumonia.
The present study could not provide direct evidence to explain how GCMT was associated with lower in-hospital mortality, because of the limited availability of data on treatment protocols. However, existing literature on this topic allowed us to speculate that two possible pathways may exist. First, GCMT could guide physicians to make a proper choice of therapeutic regimen. Second, the performance of GCMT would reflect compliance with the standardized care process, leading to better outcomes.
Several studies have supported the possibility that GCMT is effective for choosing the most appropriate treatment. Rello et al. reported that combinations of microbiological tests were useful in correcting ineffective antibiotic treatment among ∼5% of community-acquired pneumonia cases [23] . Sorde et al. also reported that urine antigen testing helped physicians select pathogen-directed antibiotics as an initial regimen [20] . Falguera et al. further revealed that the use of an initial pathogen-directed regimen decreased the incidence of adverse events, compared with empirically chosen regimens without pathogen identification [11] .
Other studies suggested that the performance of GCMT simply correlated with the other standard care process leading to improved outcomes. Jha et al. reported that guidelineconcordant processes of care, such as early antibiotic administration and monitoring of oxygenation, were associated with lower mortality [3] . Dambrava et al. also revealed that a standard care process, such as guideline-adherent empirical antibiotic therapy, was associated with a shorter length of stay [24] . Consequently, performance of GCMT may improve patient outcomes through institution of an appropriate standard of medical care.
To the best of our knowledge, this study is the first to identify that the cumulative number of GCMT components performed is associated with decreased mortality in a dose-response manner. Conducting combinations of tests might improve diagnostic precision, which should increase the odds of making correct etiological diagnoses and selecting the most effective treatment regimen [8] . The number of GCMT may also reflect the degree of compliance with the standards recommended. Several studies proposed that hospital volume was associated with adherence to the standard care process [25, 26] . When we adjusted for hospital volume as a proxy measure of the degree of process standardization, the significant association between performance of GCMT and better outcomes remained, suggesting that GCMT itself is an effective process in improving outcomes. However, the exact mechanism of how GCMT leads to better outcomes remains to be revealed in future studies that measure the performance of GCMT as well as the details of the care processes. At this stage, we could at least safely argue that the conduction of GCMT as recommended is beneficial to the outcome of patients with community-acquired pneumonia.
Limitations
The study has several limitations in addition to those discussed above. First, we could not obtain detailed clinical information about the pathogens and their drug sensitivity, which prohibited us from evaluating the treatment process, such as appropriate choice of antibiotics. We also did not have information regarding antibiotic administration within 4 h of hospitalization, and quality and sites of collection of the sputum specimens. These standard care processes could potentially confound our study results [4, 27, 28] .
Second, because of the observational nature of our study, our results may be biased by selective GCMT. A propensity-adjusted analysis produced essentially similar results. However, residual confounding by unmeasured variables cannot be excluded [29] .
Third, we retrieved GCMT information through hospital electronic order records. These provided information regarding the ordering of an examination. However, they did not necessarily prove the actual implementation of the ordered test. Nevertheless, because the records were for claims administration, we believe that they were reliable markers of actual implementation of GCMT.
Fourth, we did not include patients whose primary diagnosis was sepsis, with pneumonia as a secondary diagnosis, because the database did not include enough information on etiology. We do not believe, however, that failure to include pneumonia-based sepsis biased our results to any great extent because such cases would have severe pneumonia, and blood cultures would effectively detect the pathogens.
Fifth, we could not deny the possibility of reverse causation between low mortality and GCMT performance since GCMT might be selectively withheld in patients whose prognosis was expected to be poor (e.g., patients with a Do-Not-Resuscitate code). However, we believe this is unlikely since the DPCbased payment scheme is applied only in acute care hospitals for secondary-tertiary care.
Finally, longer lengths of stay in Japanese acute care hospitals, arguably related to a poor referral system between acute care hospitals and chronic care facilities, may limit the generalizability of our findings to other countries with a shorter length of stay [30] .
Conclusions
In our study of 65 145 patients with community-acquired pneumonia in Japan, we found a statistically significant inverse association between GCMT compliance and in-hospital mortality and length of stay. The association was stronger among the more severe community-acquired pneumonia cases. The results of our study indicate that compliance with GCMT could result in improved community-acquired pneumonia outcomes. 
